Evidence map›Paper›PMID 36627120›Full record

ArticleJournal of psychiatry & neuroscience : JPN

Is history of abuse predictive of eating disorders with binge-eating episodes through an effect mediated by impulsivity? A French longitudinal study.

Clémence Cabelguen, Anaïs Saillard, Antoine Vanier, Manuel Laslandes, Juliette Leboucher, Morgane Rousselet, Elsa Thiabaud, Marie Grall-Bronnec, Gaëlle Challet-Bouju

Open access · diamondAbstract read
In one paragraph

Article in Journal of psychiatry & neuroscience : JPN. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 4 citations in OpenAlex.

  1. Defining Recovery and Relapse in Bulimia Nervosa: A Systematic Review of the Literature.European eating disorders review : the journal of the Eating Disorders Association · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Clémence CabelguenFrom Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France (Cabelguen, Saillard, Laslandes, Leboucher, Rousselet, Thiabaud, Grall-Bronnec, Challet-Bouju); Nantes Université, Université de Tours, CHU Nantes, CHU Tours, Institut national de la santé et de la recherche médicale, SPHERE, Nantes, France (Vanier, Grall-Bronnec, Challet-Bouju); and the Pharmaceutical Drugs Assessment Department, Assessment and Access to Innovation Direction, Haute Autorité de Santé, Saint-Denis, France (Vanier).
Anaïs SaillardFrom Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France (Cabelguen, Saillard, Laslandes, Leboucher, Rousselet, Thiabaud, Grall-Bronnec, Challet-Bouju); Nantes Université, Université de Tours, CHU Nantes, CHU Tours, Institut national de la santé et de la recherche médicale, SPHERE, Nantes, France (Vanier, Grall-Bronnec, Challet-Bouju); and the Pharmaceutical Drugs Assessment Department, Assessment and Access to Innovation Direction, Haute Autorité de Santé, Saint-Denis, France (Vanier).
Antoine VanierFrom Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France (Cabelguen, Saillard, Laslandes, Leboucher, Rousselet, Thiabaud, Grall-Bronnec, Challet-Bouju); Nantes Université, Université de Tours, CHU Nantes, CHU Tours, Institut national de la santé et de la recherche médicale, SPHERE, Nantes, France (Vanier, Grall-Bronnec, Challet-Bouju); and the Pharmaceutical Drugs Assessment Department, Assessment and Access to Innovation Direction, Haute Autorité de Santé, Saint-Denis, France (Vanier).
Manuel LaslandesFrom Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France (Cabelguen, Saillard, Laslandes, Leboucher, Rousselet, Thiabaud, Grall-Bronnec, Challet-Bouju); Nantes Université, Université de Tours, CHU Nantes, CHU Tours, Institut national de la santé et de la recherche médicale, SPHERE, Nantes, France (Vanier, Grall-Bronnec, Challet-Bouju); and the Pharmaceutical Drugs Assessment Department, Assessment and Access to Innovation Direction, Haute Autorité de Santé, Saint-Denis, France (Vanier).
Juliette LeboucherFrom Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France (Cabelguen, Saillard, Laslandes, Leboucher, Rousselet, Thiabaud, Grall-Bronnec, Challet-Bouju); Nantes Université, Université de Tours, CHU Nantes, CHU Tours, Institut national de la santé et de la recherche médicale, SPHERE, Nantes, France (Vanier, Grall-Bronnec, Challet-Bouju); and the Pharmaceutical Drugs Assessment Department, Assessment and Access to Innovation Direction, Haute Autorité de Santé, Saint-Denis, France (Vanier).
Morgane RousseletFrom Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France (Cabelguen, Saillard, Laslandes, Leboucher, Rousselet, Thiabaud, Grall-Bronnec, Challet-Bouju); Nantes Université, Université de Tours, CHU Nantes, CHU Tours, Institut national de la santé et de la recherche médicale, SPHERE, Nantes, France (Vanier, Grall-Bronnec, Challet-Bouju); and the Pharmaceutical Drugs Assessment Department, Assessment and Access to Innovation Direction, Haute Autorité de Santé, Saint-Denis, France (Vanier).
Elsa ThiabaudFrom Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France (Cabelguen, Saillard, Laslandes, Leboucher, Rousselet, Thiabaud, Grall-Bronnec, Challet-Bouju); Nantes Université, Université de Tours, CHU Nantes, CHU Tours, Institut national de la santé et de la recherche médicale, SPHERE, Nantes, France (Vanier, Grall-Bronnec, Challet-Bouju); and the Pharmaceutical Drugs Assessment Department, Assessment and Access to Innovation Direction, Haute Autorité de Santé, Saint-Denis, France (Vanier).
Marie Grall-BronnecFrom Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France (Cabelguen, Saillard, Laslandes, Leboucher, Rousselet, Thiabaud, Grall-Bronnec, Challet-Bouju); Nantes Université, Université de Tours, CHU Nantes, CHU Tours, Institut national de la santé et de la recherche médicale, SPHERE, Nantes, France (Vanier, Grall-Bronnec, Challet-Bouju); and the Pharmaceutical Drugs Assessment Department, Assessment and Access to Innovation Direction, Haute Autorité de Santé, Saint-Denis, France (Vanier).
Gaëlle Challet-BoujuFrom Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France (Cabelguen, Saillard, Laslandes, Leboucher, Rousselet, Thiabaud, Grall-Bronnec, Challet-Bouju); Nantes Université, Université de Tours, CHU Nantes, CHU Tours, Institut national de la santé et de la recherche médicale, SPHERE, Nantes, France (Vanier, Grall-Bronnec, Challet-Bouju); and the Pharmaceutical Drugs Assessment Department, Assessment and Access to Innovation Direction, Haute Autorité de Santé, Saint-Denis, France (Vanier) gaelle.bouju@chu-nantes.fr.
Centre Hospitalier Universitaire de Tours · FRSanté Publique France · FRUniversité de Tours · FRImpact Assessment · USSciences, Philosophie, Histoire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years, many studies have explored the associations among impulsivity, history of abuse, the emergence of eating disorders with episodes of binge eating (EDBE) and their severity. Nevertheless, factors associated with successful clinical outcomes of EDBE are still unknown. Our study aimed to test the hypothesis that a history of abuse is associated with unsuccessful clinical outcomes of EDBE through an effect mediated by impulsivity.

methodsWe assessed patients older than 15 years, 3 months with EDBE at inclusion and at 1 year. Recovery was defined as the absence of eating disorders at 1 year. A mediation analysis was performed by means of structural equation modelling.

resultsWe included 186 patients in our analyses (54% bulimia nervosa, 29% anorexia nervosa binge eating/purging type and 17% binge-eating disorder); 179 (96%) were female. One-third ( LIMITATIONS: We excluded 219 patients lost to the 1-year follow-up.

conclusionOur findings may help to deconstruct the empirical belief that traumatic events may interfere with the successful course of treatment for eating disorders. A high level of positive urgency may be associated with more receptivity to care.

Indexed as

Anorexia NervosaBinge-Eating DisorderBulimiaFeeding and Eating DisordersFemaleHumansImpulsive BehaviorLongitudinal StudiesMale

Identifiers

PMID36627120
PMCPMC9833835
OpenAlexW4313910172

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.